Roche Gets FDA Emergency Authorization for Test for Covid-19, Flu
September 04 2020 - 07:26AM
Dow Jones News
By Matt Grossman
Roche Holding AG on Friday said it has received an emergency-use
authorization from the U.S. Food and Drug Administration for a test
that can distinguish between Covid-19 and the flu.
The test is for Roche's cobas 6800/8800 system, which can
process between 384 and 1,056 tests in an eight-hour period
depending on the model used.
Roche said the test will help health-care providers determine
which patients are sick with the flu and which are sick with
Covid-19--a determination that will grow in importance as flu
season approaches.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
September 04, 2020 07:11 ET (11:11 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2023 to Mar 2024